CIBC Private Wealth Group’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,000
Closed -$8.1K 3490
2025
Q3
$8.1K Hold
5,000
﹤0.01% 2459
2025
Q2
$12.9K Hold
5,000
﹤0.01% 2172
2025
Q1
$28.6K Hold
5,000
﹤0.01% 1852
2024
Q4
$32.5K Hold
5,000
﹤0.01% 1864
2024
Q3
$41.5K Hold
5,000
﹤0.01% 1837
2024
Q2
$32.3K Hold
5,000
﹤0.01% 1843
2024
Q1
$45.6K Buy
+5,000
New +$58.6K ﹤0.01% 1716
2021
Q1
Sell
-4,000
Closed -$276K 1038
2020
Q4
$276K Buy
+4,000
New +$196K ﹤0.01% 883

Other funds holding LUNG

CIBC Private Wealth Group's LUNG Position: Q4 2025 in Review

CIBC Private Wealth Group sold out of Pulmonx (LUNG) in Q4 2025, closing a stake of 5,000 shares — an estimated $8.1K sold.

CIBC Private Wealth Group first reported a position in LUNG in Q4 2020 and held it in 8 quarters. The position peaked at $276K in Q4 2020. 112 funds tracked by Wall St. Rank hold LUNG as of Q4 2025.

  • CIBC Private Wealth Group reported no remaining Pulmonx position as of Q4 2025 after selling out during the quarter.
  • CIBC Private Wealth Group sold 5,000 Pulmonx shares in Q4 2025, an estimated $8.1K.
  • CIBC Private Wealth Group first reported a position in Pulmonx in Q4 2020 and held it in 8 quarters.
  • CIBC Private Wealth Group's Pulmonx position peaked at $276K in Q4 2020.
  • 112 funds tracked by Wall St. Rank held Pulmonx as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.